Magnetic resonance assessment of gastrointestinal tract inflammation in Crohn’s disease using the simplified MaRIA score In a Colombian center: MAGNETIC study
DOI:
https://doi.org/10.47892/rgp.2025.454.2034Palabras clave:
Inflammatory Bowel Diseases, Crohn Disease, Dynamic Contrast Enhanced Magnetic Resonance Imaging, Diagnosis, TherapeuticsResumen
Introduction: Magnetic Resonance Enterography (MRE) is a valuable imaging modality for the evaluation and follow-up of patients with inflammatory bowel disease (IBD), particularly Crohn’s disease (CD). This study describes MRE findings in patients with suspected or confirmed CD at a national reference center for IBD in Colombia. Materials and methods: A descriptive observational study was conducted in patients evaluated with MRE at a specialized IBD center. Results: Of the 20 patients evaluated, 18 (90%) underwent MRE due to clinical or endoscopic suspicion of Crohn’s disease, while 2 patients (10%) had a previously confirmed diagnosis and were assessed for follow-up evaluation. Overall, 40% of the cohort showed findings compatible with acute inflammatory activity. Overall, 40% of the cohort showed findings compatible with acute inflammatory activity. Intestinal involvement was most frequent in the terminal ileum (40%), followed by the sigmoid colon (15%), and the descending, transverse, and cecum colon (10% each). The average ileal segment length was 37 mm, with mean parietal thickening of 5.7 mm. Mesenteric fat signal alteration was observed in 55% of patients, mesenteric lymphadenopathy in 35%, and vascular changes in 10%. Chronic fibrostenotic changes were found in 15%, and 20% showed subocclusive-type obstructions. Findings not related to IBD were noted in 35% of cases. Based on the simplified Magnetic Resonance Index of Activity (MaRIA) score, 50% had a score of 0-1, 5% scored 2, 40% scored 3, and 5% scored 5. Conclusions: The MAGNETIC study confirms MRE’s role in identifying active inflammation, chronic sequelae, and complications in Crohn’s disease. It supports the use of the MaRIA score for objective disease assessment, enhancing clinical decision-making in specialized IBD centers.
Descargas
Métricas
Citas
Baumgart DC, Sandborn WJ. Crohn’s disease. Lancet. 2012;380(9853):1590-1605. doi: 10.1016/S0140- 6736(12)60026-9.
Danese S, Vuitton L, Peyrin-Biroulet L. Biologic agents for IBD: Practical insights. Nat Rev Gastroenterol Hepatol. 2015;12(9):537-545. doi: 10.1038/nrgastro.2015.135.
Zhang YN, Liu YB, Xu J, Cao KM, Zhang XX, Wang YB, et al. Magnetic resonance index of activity (MaRIA) is reliable in assessing response to treatment in patients with Crohn’s disease (CD). Clin Radiol. 2024;79(3):230-236. doi: 10.1016/j. crad.2023.11.008.
Daperno M, D’Haens G, Van Assche G, Baert F, Bulois P, Maunoury V, et al. Development and validation of a new, simplified endoscopic activity score for Crohn’s disease: The SES-CD. Gastrointest Endosc. 2004;60(4):505-512. doi: 10.1016/s0016-5107(04)01878-4.
Fidler JL, Guimaraes L, Einstein DM. MR imaging of the small bowel. Radiographics. 2009;29(6):1811-1825. doi: 10.1148/ rg.296095507.
Ordás I, Rimola J, Alfaro I, Rodríguez S, Castro-Poceiro J, Ramírez-Morros A, et al. Development and validation of a simplified magnetic resonance index of activity for Crohn’s disease. Gastroenterology. 2019;157(2):432-439.e1. doi: 10.1053/j.gastro.2019.03.051.
Minordi LM, Larosa L, Papa A, Cimino G, Bevere A, Brizi MG, et al. A review of magnetic resonance enterography classification and quantitative evaluation of active disease in patients with Crohn’s disease. Clin Imaging. 2021;69:50-62. doi: 10.1016/j. clinimag.2020.06.006.
Juliao-Baños F, Kock J, Arrubla M, Calixto O, Camargo J, Cruz L, et al. Trends in the epidemiology of inflammatory bowel disease in Colombia by demographics and region using a nationally representative claims database and characterization of inflammatory bowel disease phenotype in a case series of Colombian patients. Medicine (Baltimore). 2021;100(7):e24729. doi: 10.1097/MD.0000000000024729.
Fernández-Ávila DG, Bernal-Macías S, Parra-Izquierdo V, Rincón-Riaño DN, Gutiérrez JM, Rosselli D. Prevalence of inflammatory bowel disease and related arthritis in Colombia, according to information from the Health and Social Protection Data System. Rev Colomb Reumatol. 2020;27(1):3-8.
Gil F, Juliao-Baños F, Amador L, Castano N, Reyes JM. Cost effectiveness of tofacitinib for the treatment of moderate to severe active ulcerative colitis in Colombia. Pharmacoecon Open. 2022;6(6):837-846. doi: 10.1007/s41669-022-00360-4.
World Medical Association. World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191-2194. doi: 10.1001/jama.2013.281053.
Ministerio de Salud. Resolución Número 8430 de 1993. Bogotá: MinSalud; 1993.
Bufman H, Eliakim R, Tau N, Amitai MM. Magnetic resonance enterography in Crohn’s disease patients: Current state of the art and future perspectives. Expert Rev Med Devices. 2021;18(7):657-667. doi: 10.1080/17434440.2021.1939682.
Lunder AK, Bakstad LT, Jahnsen J, Borthne A, Hov JR, Vatn M, Negård A. Assessment of bowel inflammation and strictures by magnetic resonance enterography in long-term Crohn’s disease. J Crohns Colitis. 2019;13(5):607-614. doi: 10.1093/ ecco-jcc/jjy208.
Yoon HM, Suh CH, Kim JR, Lee JS, Jung AY, Kim KM, et al. Diagnostic performance of magnetic resonance enterography for detection of active inflammation in children and adolescents with inflammatory bowel disease: A systematic review and diagnostic meta-analysis. JAMA Pediatr. 2017;171(12):1208- 1216. doi: 10.1001/jamapediatrics.2017.3400.
Mentzel HJ, Reinsch S, Kurzai M, Stenzel M. Magnetic resonance imaging in children and adolescents with chronic inflammatory bowel disease. World J Gastroenterol. 2014;20(5):1180-1191. doi: 10.3748/wjg.v20.i5.1180.
Cunha GM, Fowler KJ, Roudenko A, Taouli B, Fung AW, Elsayes KM, et al. How to use LI-RADS to report liver CT and MRI observations. Radiographics. 2021;41(5):1352-1367. doi: 10.1148/rg.2021200205.
Kaushal P, Somwaru AS, Charabaty A, Levy AD. MR enterography of inflammatory bowel disease with endoscopic correlation. Radiographics. 2017;37(1):116-131. doi: 10.1148/ rg.2017160064.
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2025 Viviana Parra Izquierdo, Juan Sebastián Frías-Ordoñez, Ginary Orduz Diaz, Oscar Mariano Pinto, Carlos Augusto Cuadros, Johon Francisco Garcés, Juan Javier Acevedo, Andrés Guillermo Barco, Danilo Solorzano, Julian Ferreira, Vanessa Duran, Cristian Fabián Flórez, Juancarlos Torres, Maria Stella Serrano, Samuel Cubillos Rodríguez

Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Revista de Gastroenterología del Perú by Sociedad Peruana de Gastroenterología del Perú is licensed under a Licencia Creative Commons Atribución 4.0 Internacional..
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:
- Los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación esta revista.
- Los autores/as podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un archivo telemático institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista.
- Se permite y recomienda a los autores/as difundir su obra a través de Internet (p. ej.: en archivos telemáticos institucionales o en su página web) antes y durante el proceso de envío, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada. (Véase El efecto del acceso abierto).








2022